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Abstract
© 2018 Ruslania. All Rights Reserved. Cholinergic synaptic contact between motor neuron and
skeletal  muscle  fiber  is  perhaps  one  of  the  core  objects  for  investigations  of  molecular
mechanisms  underlying  the  communication  between  neurons  and  innervated  cells.  In  the
studies conducted on this object in the past few decades, a large amount of experimental data
was obtained that substantially complemented a traditional view on synaptic transmission. In
particular, it was established that (i) acetylcholine is released from the nerve ending in both
quantal  and non-quantal  ways;  (ii)  molecular  mechanisms of  the processes of  the quantal
acetylcholine release - spontaneous and evoked by electrical stimuli - have unique features and
can  be  regulated  independently;  (iii)  acetylcholine  release  from  the  nerve  ending  is
accompanied  by  a  release  of  a  number  of  synaptically  active  molecules  modulating  the
processes of secretion or reception of the main mediator; (iv) signal molecules affecting the
process of cholinergic neurosecretion can be released not only from the nerve ending but also
from glial  cells  and muscle  fiber;  (v)  molecular  mechanisms of  the regulation of  synaptic
transmission are highly diverse and go beyond the alteration of the number of the released
acetylcholine  quanta.  Thus,  the  neuromuscular  junction  shall  be  deemed  currently  as
complicated and adaptive synapse characterized by a wide range of multi-loop intercellular
signaling pathways between presynaptic motor neuron ending, muscle fiber,  and glial  cells
ensuring a high safety factor of synaptic transmission and the possibility of its fine tuning.
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